In 2020, the WHO published a road map for NTDs (including Buruli ulcer) targeted for eradication from 2021 to 2030. In this road map, access to better nutrition to strengthen the immune systems and reduce susceptibility was noted. BU is known to be endemic in poor remote rural communities in some parts of West Africa (including Ghana). Although Ghana is undergoing a shift in nutrition, the changes are not ongoing in the rural area but for micronutrients, no evolution has been reported. Malnutrition and undernutrition continue to be reported in rural Ghana.
Nutrition is known to play a role in the pathogenesis of infectious diseases like leprosy and tuberculosis, yet little is known regarding the nutritional profile of communities in Ghana where BU is endemic, the level of risk malnutrition poses to disease predisposition, and how good nutrition may help ameliorate progression in those with the disease.
Our main aim is to investigate the pathogenesis of Buruli ulcer from the perspective of the nutrition, infection, and immune response paradigm.
- To measure the serum levels of nutritional markers (zinc, selenium, vitamin c, and vitamin B12), and inflammatory markers (high sensitivity CRP, IL-1β, IL-6, TNF-α, IFN- γ) in archived samples of 80 BU patients and 80 matched controls
- To use existing clinical data for these samples along with the acquired data to assess the following parameters:
- Correlations between serum nutritional status and acute phase response markers
- Relative levels of all markers in BU patients vs. controls
- Relative levels of all markers in BU patients with different disease severity
- Relative levels of all markers vs. the time taken for BU patients to heal completely
- Relative levels of all markers vs. BMI in BU patients and controls
The expected outcome of this study includes:
- It will be of relevance to the WHO NTD eradication agenda
- it will substantially increase our understanding of the pathogenic mechanism of BU development
- it will contribute to knowledge on the role of diet in BU pathogenesis
Evaluation of a nitric oxide generating dressing (EDX110) to improve management of Buruli ulcer disease
Laboratory support for the control and elimination of skin NTDs (Buruli ulcer, yaws and leprosy) in Ghana.
A randomised controlled trial to evaluate the effect of High Dose Rifampicin and Dialkylcarbamoyl chloride (DACC)-coated dressings on outcomes in Mycobacterium ulcerans disease
Training Health Workers and to Implement Case Detection for SkinNTD in Ghana (THECA-DES)
Training and field evaluation of new diagnostic tool for Buruli ulcer in Ghana